| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Chief Operating Officer | Restricted Stock Units | 18K | $1.36M | $75.18 | Feb 27, 2024 | Direct |
| Axsome Therapeutics, Inc. | Chief Operating Officer | Common Stock | 5.78K | $487K | $84.26 | Aug 9, 2024 | Direct |
| Axsome Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 0 | Aug 9, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | Aug 9, 2024 | 3 | -$3.83M | 4 | Aug 9, 2024 | Chief Operating Officer |
| AXSM | Axsome Therapeutics, Inc. | May 29, 2024 | 3 | -$570K | 4 | May 29, 2024 | Chief Operating Officer |
| AXSM | Axsome Therapeutics, Inc. | Apr 1, 2024 | 3 | -$1.87M | 4 | Apr 1, 2024 | Chief Operating Officer |
| AXSM | Axsome Therapeutics, Inc. | Feb 27, 2024 | 2 | $0 | 4 | Feb 29, 2024 | CHIEF OPERATING OFFICER |
| AXSM | Axsome Therapeutics, Inc. | Mar 2, 2023 | 2 | $0 | 4 | Mar 6, 2023 | CHIEF OPERATING OFFICER |
| AXSM | Axsome Therapeutics, Inc. | Mar 4, 2022 | 2 | $0 | 4 | Mar 8, 2022 | CHIEF OPERATING OFFICER |
| AXSM | Axsome Therapeutics, Inc. | Nov 12, 2021 | 1 | $0 | 4 | Nov 15, 2021 | CHIEF OPERATING OFFICER |